Cancer patients twice as likely to die from COVID-19: study

  • 📰 YahooSG
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 71%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

People with cancer are more than twice as likely to die from COVID-19 than those without it, a large study published Thursday found. The data on more than 900 patients in the US, Canada and Spain which appeared in a paper in The Lancet, found that mortality increased the further the cancer had progressed

People with cancer are more than twice as likely to die from COVID-19 than those without it, a large study published Thursday found.

The paper's authors looked at how many people died within 30 days of being diagnosed of COVID-19 of all causes. But the receipt of chemotherapy or other anti-cancer therapies within four weeks of COVID-19 diagnosis did not affect mortality outcomes.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Cancer patients twice as likely to die from COVID-19: studyPeople with cancer are more than twice as likely to die from COVID-19 than those without it, a large study published Thursday found. The data on more than 900 patients in the US, Canada and Spain which appeared in a paper in The Lancet, found that mortality increased the further the cancer had progressed
Source: YahooSG - 🏆 3. / 71 Read more »

Hydroxychloroquine combination risky for cancer patients with Covid-19: StudyCHICAGO (REUTERS) - Cancer patients with Covid-19 who were treated with a drug combination promoted by US President Donald Trump to counter the coronavirus were three times more likely to die within 30 days than those who got either drug alone, US researchers reported on Thursday (May 28).. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Hydroxychloroquine combination risky for cancer patients with COVID-19: StudyCancer patients with COVID-19 who were treated with a drug combination promoted by U.S. President Donald Trump to counter the coronavirus were ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Roche to study remdesivir/Actemra cocktail against severe Covid-19 pneumoniaZURICH (REUTERS) - Swiss drugmaker Roche said on Thursday (May 28) it would study its anti-inflammation drug Actemra mixed with Gilead Science's remdesivir in hospitalised patients with severe Covid-19 pneumonia in a global trial of around 450 patients.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Remdesivir study finds hospital stays for Covid-19 patients could be reduced without affecting treatment outcomeHONG KONG — A major study of the experimental antiviral drug remdesivir found that Covid-19 patients could be discharged from hospital five days earlier with a similar treatment outcome, a Hong Kong expert said, as the city reached 14 days without local transmission on Thursday (May 28).
Source: TODAYonline - 🏆 1. / 99 Read more »

Future of English women's game faces threat due to COVID-19 says studyREUTERS: The future of English women's soccer faces an unprecedented threat as a result of the COVID-19 pandemic and decisive action must be taken ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »